Editing Lassa fever (section)

==Prevention==
{{Main|Prevention of viral hemorrhagic fever}}
[[File:LassaRat.png|thumb|Community education material for Lassa fever]]
Control of the ''[[Mastomys]]'' rodent population is impractical, so measures focus on keeping rodents out of homes and food supplies, encouraging effective personal hygiene, storing grain and other foodstuffs in rodent-proof containers, and disposing of garbage far from the home to help sustain clean households.<ref name="pmid17378212">{{cite journal |vauthors=Ogbu O, Ajuluchukwu E, Uneke CJ |title=Lassa fever in West African sub-region: an overview |journal=J Vector Borne Dis |volume=44 |issue=1 |pages=1–11 |date=March 2007 |pmid=17378212 |doi= |url=}}</ref> Gloves, masks, laboratory coats, and goggles are advised while in contact with an infected person, to avoid contact with blood and body fluids.<ref name="weber">{{cite journal |vauthors=Weber DJ, Rutala WA, Fischer WA, Kanamori H, Sickbert-Bennett EE |title=Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9) |journal=Am J Infect Control |volume=44 |issue=5 Suppl |pages=e91–e100 |date=May 2016 |pmid=27131142 |pmc=7132650 |doi=10.1016/j.ajic.2015.11.018 |url=}}</ref> These issues in many countries are monitored by a department of [[public health]]. In less developed countries, these types of organizations may not have the necessary means to effectively control outbreaks.<ref>{{Citation |title=Driving and Public Health |date=2021-11-23 |url=http://dx.doi.org/10.1093/obo/9780199756797-0211 |work=Public Health |publisher=Oxford University Press |doi=10.1093/obo/9780199756797-0211 |isbn=978-0-19-975679-7 |access-date=2022-04-23}}</ref>

===Vaccine===
There is no [[vaccine]] for humans as of 2023.<ref name=VHFC2019>{{cite web |title=Lassa |url=https://vhfc.org/diseases/lassa/ |website=Viral Hemorrhagic Fever Consortium |access-date=18 June 2019 |archive-date=18 June 2019 |archive-url=https://web.archive.org/web/20190618110029/https://vhfc.org/diseases/lassa/ |url-status=live }}</ref> Researchers at the [[United States Army Medical Research Institute of Infectious Diseases]] facility had a promising vaccine candidate in 2002.<ref>{{cite book |author=Preston, Richard |title=The demon in the freezer: a true story |url=https://archive.org/details/demoninfreezertr00pres |url-access=registration |publisher=Random House |location=New York |year=2002 |isbn=978-0-375-50856-1 |author-link=Richard Preston }}</ref> They have developed a [[Virus#Replication cycle|replication]]-competent vaccine against Lassa virus based on recombinant vesicular [[stomatitis]] [[Vesicular stomatitis virus|virus]] vectors expressing the Lassa virus glycoprotein. After a single [[intramuscular injection]], test primates have survived lethal challenge, while showing no clinical symptoms.<ref>{{cite journal |author=Geisbert TW |title=Development of a New Vaccine for the Prevention of Lassa Fever |journal=PLOS Med. |volume=2 |issue=6 |pages=e183 |year=2005 |pmid=15971954 |doi=10.1371/journal.pmed.0020183 |pmc=1160587 |author2=Jones S |author3=Fritz EA |last4=Shurtleff |first4=Amy C. |last5=Geisbert |first5=Joan B. |last6=Liebscher |first6=Ryan |last7=Grolla |first7=Allen |last8=Ströher |first8=Ute |last9=Fernando |first9=Lisa |doi-access=free }}</ref>